Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- Belgian EU presidency presents new risk assessment methodology for child sexual abuse law
- French minister: Agriculture will be national ‘major general interest’
- PFAS bill takes first step in French Parliament
- The Brief – A more French EU around the corner?
- Belarus’ democratic forces fail to align messaging on EU sanctions
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
09 Apr 2024
Subscribe to our jobletter!